Given the importance of Wnt/β-catenin in the mammary gland tumorigenesis in triple negative, mesenchymal breast cancers [36], we speculate that DACT3 represents a potential therapeutic target for these carcinomas. The gene discussed is DACT3; the disease is breast carcinoma.